Adesão de pacientes ao tratamento com antineoplásicos orais: fatores influentes

Silva, Ana Gabriela; Azevedo, Cissa; Mata, Luciana Regina Ferreira da; Vasques, Christiane Inocêncio.
Rev. baiana enferm ; 31(1): e16428, 2017. tab
Artículo en Portugués | LILACS, BDENF - Enfermería | ID: biblio-897440

Documentos relacionados

  1. Determinants of cancer drug pricing and how to overcome the cancer premium.
  2. Amplifying "eat me signal" by immunogenic cell death for potentiating cancer immunotherapy.
  3. Immunosurveillance in clinical cancer management.
  4. Connecting communities to tackle cancer from many sides.
  5. Challenges and opportunities in oncology drug development and clinical research in China.
  6. Type I interferon and cancer.
  7. Nanomedicine as potential cancer therapy via targeting dysregulated transcription factors.
  8. MMCL-CDR: enhancing cancer drug response prediction with multi-omics and morphology images contrastive representation learning.
  9. Direct K-Ras Inhibitors to Treat Cancers: Progress, New Insights, and Approaches to Treat Resistance.
  10. Oncogenic signals prime cancer cells for toxic cell overgrowth during a G1 cell cycle arrest.